These questions arise in part from social-media-driven interest in the compound and in part from what limited early data exist
In the near term, agencies will process delayed FY25 proposals without a unified restart timeline
All three doses of orforglipron (6 mg, 12 mg, and 36 mg) studied in that trial met the primary and all key secondary endpoints by showing significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors compared with placebo at 72 weeks
Our mission extends beyond treating illness
In other words, it helps you exercise for longer periods at a time
To view a copy of this licence, visit About this article Cite this article Park, S.J., Park, Y.J., Chang, J